InCephalo is a preclinical stage biotech company with a compartment locked (CLocked) technology. InCephalo is positioning itself as a CLocked Fc-Fusion Cytokine and antibody company. The company’s first asset is a CLocked IL-12Fc for the treatment of glioblastoma.


Gewerbestrasse 24, 4123 Allschwil, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation


  • Number of employees in Switzerland


Key business